Arkema S.A.

Informe acción ENXTPA:AKE

Capitalización de mercado: €7.3b

Arkema Crecimiento futuro

Future controles de criterios 2/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Arkema de 15.5% y 3.9% por año respectivamente. Se prevé que el BPA crezca en un 15.6% al año. Se espera que la rentabilidad financiera sea de 10.5% en 3 años.

Información clave

15.5%

Tasa de crecimiento de los beneficios

15.6%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Chemicals10.3%
Tasa de crecimiento de los ingresos3.9%
Rentabilidad financiera futura10.5%
Cobertura de analistas

Good

Última actualización09 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Mar 02
Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Recent updates

Arkema (EPA:AKE) Has Announced That It Will Be Increasing Its Dividend To €3.50

Apr 25
Arkema (EPA:AKE) Has Announced That It Will Be Increasing Its Dividend To €3.50

Is Arkema (EPA:AKE) A Risky Investment?

Mar 29
Is Arkema (EPA:AKE) A Risky Investment?

Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.50

Mar 08
Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.50

Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Mar 02
Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

Dec 30
Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

An Intrinsic Calculation For Arkema S.A. (EPA:AKE) Suggests It's 37% Undervalued

Dec 15
An Intrinsic Calculation For Arkema S.A. (EPA:AKE) Suggests It's 37% Undervalued

Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Nov 29
Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Does Arkema (EPA:AKE) Have A Healthy Balance Sheet?

Sep 07
Does Arkema (EPA:AKE) Have A Healthy Balance Sheet?

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 44%?

Aug 20
Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 44%?

Is It Too Late To Consider Buying Arkema S.A. (EPA:AKE)?

Aug 02
Is It Too Late To Consider Buying Arkema S.A. (EPA:AKE)?

Arkema (EPA:AKE) Takes On Some Risk With Its Use Of Debt

May 28
Arkema (EPA:AKE) Takes On Some Risk With Its Use Of Debt

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.40

May 13
Arkema (EPA:AKE) Is Increasing Its Dividend To €3.40

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 25%?

May 09
Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 25%?

Why Arkema S.A. (EPA:AKE) Could Be Worth Watching

Apr 24
Why Arkema S.A. (EPA:AKE) Could Be Worth Watching

Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.40

Apr 05
Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.40

Arkema's (EPA:AKE) Dividend Will Be Increased To €3.40

Feb 26
Arkema's (EPA:AKE) Dividend Will Be Increased To €3.40

Arkema (EPA:AKE) Has A Somewhat Strained Balance Sheet

Feb 14
Arkema (EPA:AKE) Has A Somewhat Strained Balance Sheet

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 31%?

Jan 30
Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 31%?

Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Jan 14
Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Here's Why Arkema (EPA:AKE) Can Manage Its Debt Responsibly

Nov 02
Here's Why Arkema (EPA:AKE) Can Manage Its Debt Responsibly

At €76.10, Is Arkema S.A. (EPA:AKE) Worth Looking At Closely?

Oct 11
At €76.10, Is Arkema S.A. (EPA:AKE) Worth Looking At Closely?

Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

Jul 19
Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

What Is Arkema S.A.'s (EPA:AKE) Share Price Doing?

Jul 04
What Is Arkema S.A.'s (EPA:AKE) Share Price Doing?

If You Like EPS Growth Then Check Out Arkema (EPA:AKE) Before It's Too Late

Jun 03
If You Like EPS Growth Then Check Out Arkema (EPA:AKE) Before It's Too Late

Arkema's (EPA:AKE) Upcoming Dividend Will Be Larger Than Last Year's

May 10
Arkema's (EPA:AKE) Upcoming Dividend Will Be Larger Than Last Year's

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.00

Apr 25
Arkema (EPA:AKE) Is Increasing Its Dividend To €3.00

Is There An Opportunity With Arkema S.A.'s (EPA:AKE) 47% Undervaluation?

Apr 24
Is There An Opportunity With Arkema S.A.'s (EPA:AKE) 47% Undervaluation?

Arkema (EPA:AKE) Has Announced That It Will Be Increasing Its Dividend To €3.00

Apr 10
Arkema (EPA:AKE) Has Announced That It Will Be Increasing Its Dividend To €3.00

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.00

Mar 27
Arkema (EPA:AKE) Is Increasing Its Dividend To €3.00

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.00

Feb 27
Arkema (EPA:AKE) Is Increasing Its Dividend To €3.00

Is Now The Time To Put Arkema (EPA:AKE) On Your Watchlist?

Feb 15
Is Now The Time To Put Arkema (EPA:AKE) On Your Watchlist?

Here's Why Arkema (EPA:AKE) Can Manage Its Debt Responsibly

Feb 02
Here's Why Arkema (EPA:AKE) Can Manage Its Debt Responsibly

When Should You Buy Arkema S.A. (EPA:AKE)?

Jan 08
When Should You Buy Arkema S.A. (EPA:AKE)?

Arkema S.A.'s (EPA:AKE) Intrinsic Value Is Potentially 27% Above Its Share Price

Dec 26
Arkema S.A.'s (EPA:AKE) Intrinsic Value Is Potentially 27% Above Its Share Price

Is Now The Time To Put Arkema (EPA:AKE) On Your Watchlist?

Nov 16
Is Now The Time To Put Arkema (EPA:AKE) On Your Watchlist?

Is Arkema (EPA:AKE) A Risky Investment?

Nov 04
Is Arkema (EPA:AKE) A Risky Investment?

Is Arkema S.A. (EPA:AKE) Potentially Undervalued?

Oct 04
Is Arkema S.A. (EPA:AKE) Potentially Undervalued?

Previsiones de crecimiento de beneficios e ingresos

ENXTPA:AKE - Estimaciones futuras de los analistas y datos financieros pasados (EUR Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/202610,6867837131,42910
12/31/202510,2426905811,31013
12/31/20249,8276164971,26614
12/31/20239,5144026381,272N/A
9/30/20239,7993935831,267N/A
6/30/202310,4455036881,382N/A
3/31/202311,1877528051,489N/A
12/31/202211,5509497891,496N/A
9/30/202211,5431,0506561,347N/A
6/30/202210,9691,0732981,013N/A
3/31/202210,1801,498166914N/A
12/31/20219,5191,293152915N/A
9/30/20219,0041,212193905N/A
6/30/20218,5151,0574571,132N/A
3/31/20218,0223505231,163N/A
12/31/20207,8843045101,115N/A
9/30/20207,9523126801,288N/A
6/30/20208,2593656151,232N/A
3/31/20208,6114225431,161N/A
12/31/20198,7384916651,300N/A
9/30/20198,8925615961,247N/A
6/30/20198,8435906141,263N/A
3/31/20198,8596335641,201N/A
12/31/20188,8166744381,029N/A
9/30/20188,566685433961N/A
6/30/20188,418653461943N/A
3/31/20188,3465945371,005N/A
12/31/20178,3265435491,008N/A
9/30/20178,221492N/A904N/A
6/30/20178,040446N/A877N/A
3/31/20177,794433N/A833N/A
12/31/20167,535394N/A821N/A
9/30/20167,443390N/A955N/A
6/30/20167,551355N/A863N/A
3/31/20167,705341N/A885N/A
12/31/20157,683285N/A858N/A
9/30/20157,354263N/A640N/A
6/30/20156,886226N/A587N/A
3/31/20156,300144N/A481N/A
12/31/20145,952167N/A507N/A
9/30/20145,932161N/A520N/A
6/30/20145,949202N/A577N/A
3/31/20146,058275N/A523N/A
12/31/20136,098168N/A467N/A
9/30/20136,134192N/A482N/A
6/30/20136,245250N/A485N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (15.5% al año) de AKE es superior a la tasa de ahorro (1%).

Beneficios vs. Mercado: Se prevé que los beneficios (15.5% al año) de AKE crezcan más rápidamente que el mercado French (10.7% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de AKE crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (3.9% al año) de AKE crezcan más despacio que el mercado de French (5.7% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 3.9% al año) de AKE crezcan más despacio que 20% al año.


Previsiones de crecimiento de los beneficios por acción


Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de AKE sea baja dentro de 3 años (10.5%).


Descubre empresas en crecimiento

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target